These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38222098)

  • 1. New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation.
    Lai Y; Xu X; Zhang S; Huang R; Huang Y; Zhong X; Xiong Z; Lin Y; Zhou H; Guo Y; Liao X; Ma Y; Zhuang X
    Glob Heart; 2024; 19(1):3. PubMed ID: 38222098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy.
    Andrade JG; Roy D; Wyse DG; Tardif JC; Talajic M; Leduc H; Tourigny JC; Shohoudi A; Dubuc M; Rivard L; Guerra PG; Thibault B; Dyrda K; Macle L; Khairy P
    Heart Rhythm; 2016 Jan; 13(1):54-61. PubMed ID: 26299677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between resting heart rate and peak VO2: A comparison of atrial fibrillation and sinus rhythm.
    Kato Y; Suzuki S; Uejima T; Semba H; Nagayama O; Hayama E; Yamashita T
    Eur J Prev Cardiol; 2016 Sep; 23(13):1429-36. PubMed ID: 26879567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    Frasure-Smith N; Lespérance F; Talajic M; Khairy P; Dorian P; O'Meara E; Roy D
    Circ Heart Fail; 2012 May; 5(3):322-30. PubMed ID: 22441774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
    Proietti M; Romiti GF; Olshansky B; Lip GYH
    Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rate assessment between resting heart rate and 24-hour Holter monitoring in patients with chronic atrial fibrillation.
    Srisukwattana A; Krittayaphong R
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S111-6. PubMed ID: 22574539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
    Groenveld HF; Tijssen JG; Crijns HJ; Van den Berg MP; Hillege HL; Alings M; Van Veldhuisen DJ; Van Gelder IC;
    J Am Coll Cardiol; 2013 Feb; 61(7):741-8. PubMed ID: 23410544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of timing in treatment of atrial fibrillation: An AFFIRM substudy.
    Yang E; Tang O; Metkus T; Berger RD; Spragg DD; Calkins HG; Marine JE
    Heart Rhythm; 2021 May; 18(5):674-681. PubMed ID: 33383228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial.
    Maan A; Zhang Z; Qin Z; Wang Y; Dudley S; Dabhadakar K; Refaat M; Mansour M; Ruskin JN; Heist EK
    Pacing Clin Electrophysiol; 2017 Jul; 40(7):770-778. PubMed ID: 28543286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.
    Shariff N; Desai RV; Patel K; Ahmed MI; Fonarow GC; Rich MW; Aban IB; Banach M; Love TE; White M; Aronow WS; Epstein AE; Ahmed A
    Am J Med; 2013 Oct; 126(10):887-93. PubMed ID: 24054956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is heart rate important for patients with heart failure in atrial fibrillation?
    Cullington D; Goode KM; Zhang J; Cleland JG; Clark AL
    JACC Heart Fail; 2014 Jun; 2(3):213-20. PubMed ID: 24952686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial Fibrillation.
    Elshazly MB; Wilkoff BL; Tarakji K; Wu Y; Donnellan E; Abi Khalil C; Asaad N; Jaber W; Wazni O; Cho L
    Circ Heart Fail; 2021 Feb; 14(2):e007451. PubMed ID: 33478244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting heart rate trajectories and myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: The Tromsø Study.
    Sharashova E; Wilsgaard T; Løchen ML; Mathiesen EB; Njølstad I; Brenn T
    Eur J Prev Cardiol; 2017 May; 24(7):748-759. PubMed ID: 28121181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    J Cardiol; 2023 May; 81(5):441-449. PubMed ID: 36427691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.